Pediapharm Inc. (CVE:PDP – Get Free Report) shot up 1.7% on Friday . The company traded as high as C$0.31 and last traded at C$0.30. 26,000 shares traded hands during trading, a decline of 74% from the average session volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Stock Up 1.7 %
The company has a market cap of C$66.36 million and a P/E ratio of -4.11. The stock has a 50-day moving average of C$0.30 and a two-hundred day moving average of C$0.30. The company has a debt-to-equity ratio of 186.87, a quick ratio of 0.71 and a current ratio of 1.12.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Recommended Stories
- Five stocks we like better than Pediapharm
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the Hang Seng index?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How to Start Investing in Real Estate
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
